BCART — Biocartis NV Share News
0.000.00%
Last trade - 00:00HealthcareBalancedMicro Cap
Brief: Fire Incident At Biocartis Warehouse In Mechelen, Belgium
Brief: Biocartis Gets EUR 1.4 Mln Grant For New Idylla Technology
Brief: Biocartis Expands Collaboration Agreement With Astrazeneca
Biocartis: Jumps on strong Q1 growth in commercial cartridges
Brief: Biocartis End-Q1 Cash Position Amounted To 108.1 Million Euros
Brief: Biocartis Group NV - Biocartis And Skylinedx Sign Collaboration To Develop Merlin Assay Test
Brief: Biocartis Announces First U.S. FDA Oncology Assay Submission
Brief: Biocartis Group Launches Idylla™ GeneFusion Assay
Brief: Biocartis Group NV - FY Total Operating Income Increased Year-Over-Year By 47% To EUR 55.6M
Brief: Biocartis Announces Publication Of U.S. Studies On Idylla EGFR
Brief: Biocartis Group Meets 2020 Key Objectives
Brief: Biocartis Announces Issue Of 1,163,575 New Shares
Brief: Biocartis Converts EUR 15 Million Of Its Convertible Bonds
Brief: Biocartis Group Announces Publication Of Large Multi-Center Comparison Study With Idylla™ MSI Assay
Brief: Biocartis Ups FY Cash Position Target To Around EUR 120 Mln
Brief: Biocartis Announces CE-Marking Of Its Idylla SARS-CoV-2 Test
Brief: Biocartis And GeneproDx To Collaborate On Fully Automated ThyroidPrint® Test On Idylla
Brief: Biocartis Announces Partnership With Endpoint Health
Brief: Biocartis And Exact Sciences Agree To End Collaboration